Pfizer Company had also clearly invested hundreds of millions. They were determined to win a battle of cash flow against Jin Pharmaceutical Group!
Xie Bin's team had a clear objective: to tank Jin Pharmaceutical Group's stock price and shatter its cash flow. They were willing to throw tens of billions, even hundreds of billions, at the problem. As long as they won, they would recoup their investment many times over.
The situation for Jin Pharmaceutical Group, however, was completely different.
They simply couldn't afford a protracted battle. On one hand, their stock was plummeting as numerous investors began to pull their funding and dump their shares. On the other hand, they couldn't just give up on the Yangzheng Xiujie Pill, which had already been approved for the market. Production had to continue, and the drug had to be launched.
The only problem was that its expected market share had been drastically reduced, and their initial negotiating leverage had evaporated.
